Specify a stock or a cryptocurrency in the search bar to get a summary
Revenio Group Corporation
R0VRevenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, rest of Europe, North America, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; and iCare TONOVET an IOP measuring on animal patients by general veterinary practitioners, veterinary ophthalmologists, and other veterinary medical personnel. It also provides imaging devices comprising iCare EIDON AF, a device with confocal retinal imaging; and DRSplus, a device for pupil imaging; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. In addition, the company offers Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland. Address: Äyritie 22, Vantaa, Finland, 01510
Analytics
WallStreet Target Price
26.78 EURP/E ratio
46.0822Dividend Yield
1.13 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures R0V
Dividend Analytics R0V
Dividend growth over 5 years
-54 %Continuous growth
3 yearsPayout Ratio 5 years average
68 %Dividend History R0V
Stock Valuation R0V
Financials R0V
Results | 2019 | Dynamics |